Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers August 18, 2017
Pharmacy Choice - News - U.S. Pharmaceutical Industry - August 18, 2017

Pharmacy News

 U.S. Pharmaceutical Industry
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

8/11/17 - "Parenteral Glucagon Formulations" in Patent Application Approval Process (USPTO 20170202926)
By a News Reporter-Staff News Editor at Drug Week A patent application by the inventor Chen, Andrew, filed on March 30, 2017, was made available online on July 27, 2017, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application is assigned to Latitude Pharmaceuticals, Inc.. Hypokit from Novo
8/11/17 - "Pharmaceutical Compositions of Metabotropic Glutamate 5 Receptor (Mglu5) Antagonists" in Patent Application Approval Process (USPTO 20170202819)
By a News Reporter-Staff News Editor at Drug Week A patent application by the inventors Chatterji, Ashish; Huang, Jingjun; Koennings, Stephanie; Lindenstruth, Kai; Sandhu, Harpreet; Shah, Navnit, filed on January 11, 2017, was made available online on July 27, 2017, according to news reporting originating from Washington, D.C., by NewsRx correspo
8/11/17 - "Pharmaceutical Dosage Forms" in Patent Application Approval Process (USPTO 20170202808)
By a News Reporter-Staff News Editor at Drug Week A patent application by the inventors BEATO, Stefania; QUINTON, Peggy, filed on July 6, 2015, was made available online on July 27, 2017, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application has not been assigned to a company or instituti
8/11/17 - Accelerating generic drug approvals will save lives and dollars
Scott Gottlieb is a little different from some of his more bureaucratic predecessors: He's listening. Last month, the commissioner of the Food and Drug Administration hosted a public meeting to solicit input from patients, care providers, and drug makers on how to improve the FDA's drug approval process and, just as importantly, expedite the introd
8/11/17 - Animal Health Generics 2017: Intellectual Property and Patents, Regulation Issues, Strategies for R&D and Generics Companies, Company Profiles, Industry Associates
The "Animal Health Generics 2017: Intellectual Property and Patents, Regulation Issues, Strategies for R&D and Generics Companies, Company Profiles, Industry Associates" report has been added to Research and Markets' offering.. Intellectual Property 2.1 Summary 2.2 Introduction 2.3 WIPO 2.4 Patents 2.4. 1 Types of patent 2.4. 2 Company example 2.
8/11/17 - Arrow Seldinger Arterial Catheterization Device Receives FDA Market Clearance
By a News Reporter-Staff News Editor at Health& Medicine Week Teleflex Incorporated, a leading global provider of medical technologies for critical care and surgery, has announced that its Arrow Seldinger Arterial Catheterization Device received market clearance from the U.S. Food and Drug Administration. "As we continue to discover new and i
8/11/17 - Azurrx Biopharma, Inc. Files SEC Form S-1, General Form For Registration of Securities Under The Securities Act of 1933: (Jul. 21, 2017)
By a News Reporter-Staff News Editor at Drug Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Azurrx Biopharma, Inc. was posted on July 20, 2017. The SEC file number is 0001654954-17-006580.. A U.S. Securities and Exchange Commission filing is a formal d
8/11/17 - BeiGene Announces Pricing of $175 Million Public Offering
BeiGene, Ltd., a clinical-stage biopharmaceutical company developing innovative molecularly targeted and immuno-oncology drugs for the treatment of cancer, today announced the pricing of its follow-on public offering of 2,465,000 American Depositary Shares, each representing 13 of its ordinary shares, par value $0.0001 per share, at a price to th
8/11/17 - Beta Cat Pharmaceuticals, Houston, Assigned Patent for Anthracene-9, 10-Dione Dioxime Compound Prodrugs
Beta Cat Pharmaceuticals, Houston, has been assigned a patent developed by five co-inventors for "anthracene-9, 10- dione dioxime compound prodrugs and their uses." The co-inventors are Hariprasad Vankayalapati, Draper, Utah, Xiaohui Liu, Holladay, Utah, Sunil Sharma, Salt Lake City, Srinivas Rao Kasibhatla, San Diego, and Seelam Venkata Reddy, Tel
8/11/17 - Bonti Announces Topline Results of EB-001 Phase 2A Clinical Study in Glabellar Lines [Tehran Times (Iran)]
Bonti, a privately-held, clinical-stage biotechnology company, today announced topline results of the first clinical study of its lead product candidate, EB-001, in glabellar lines. The study achieved its objectives and confirmed both favorable safety and the expected clinical efficacy profile. EB-001 is a novel serotype E botulinum neurotoxin with
8/11/17 - Chiasma Reaches Agreement with FDA Under Special Protocol Assessment for a New Phase 3 Clinical Trial of Octreotide Capsules in Acromegaly [T-break Tech (Middle East)]
-Chiasma, Inc., a clinical-stage biopharmaceutical company focused on improving the lives of patients with rare and serious chronic diseases, today announced it has reached agreement with the U.S. Food and Drug Administration on the design of a new Phase 3 clinical trial for its octreotide capsules product candidate, conditionally trade-named Mycap
8/11/17 - Commentary ? Health Care Financing: Out the roof medication costs
Yet, even though we pay more for our prescription medication than does the rest of the free world, Congress passed a law several years ago which prohibited Medicare from negotiating the price of medication directly with the pharmaceutical companies. We pay about twice as much as a citizen of Canada for Brand Name meds. Try checking your brand name
8/11/17 - Cti Biopharma Corp. Files SEC Form 3, Initial Statement of Beneficial Ownership of Securities: (Jul. 25, 2017)
By a News Reporter-Staff News Editor at Drug Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Cti Biopharma Corp. was posted on July 25, 2017. The SEC file number is 0000899243-17-018916.. A U.S. Securities and Exchange Commission filing is a formal docu
8/11/17 - Cti Biopharma Corp. Files SEC Form 4, Statement of Changes in Beneficial Ownership of Securities: (Jul. 25, 2017)
By a News Reporter-Staff News Editor at Drug Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Cti Biopharma Corp. was posted on July 25, 2017. The SEC file number is 0000899243-17-018917.. A U.S. Securities and Exchange Commission filing is a formal docu
8/11/17 - Cti Biopharma Corp. Files SEC Form 8-K, Current Report: (Jul. 24, 2017)
By a News Reporter-Staff News Editor at Drug Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Cti Biopharma Corp. was posted on July 24, 2017. The SEC file number is 0000891293-17-000080.. A U.S. Securities and Exchange Commission filing is a formal docu
8/11/17 - CURE Pharmaceutical Enters Partnership to Distribute New Erectile Dysfuntion Drug Using Companys Proprietary CureFilm Into Asian Market [Times of Oman]
-CURE Pharmaceutical,, a leading disruptive drug delivery technology and pharmaceutical cannabinoid molecule development company, today announced that it has partnered with a leading pharmaceutical distribution company to deliver a generic erectile dysfunction drug on its patented, multilayer oral thin film, CureFilm, into the Asian market.
8/11/17 - Data from Northeastern University Provide New Insights into Drug Delivery Systems (Elastic liposomes as novel carriers: recent advances in drug...
The news reporters obtained a quote from the research from Northeastern University, "Increased drug encapsulation efficiency, enhanced drug permeation and penetration into or across the skin, and ultradeformability have led to widespread interest in ELs to modulate drug release, permeation, and drug action more efficiently than conventional...
8/11/17 - EDITORIAL: Trump was given a plan for easing the opioid crisis. He should follow it. [Bangor Daily News, Maine]
Aug. 10 President Donald Trump had the opportunity this week to be the strong leader that is needed to change policies and attitudes about addiction to better address the country's opioid crisis. Chris Christie, did not call for the hiring of more police officers or the construction of a border wall to reduce the flow of illegal drugs through Mex
8/11/17 - Eisai Submits Supplemental New Drug Application to FDA for Lenvatinib in First-Line Hepatocellular Carcinoma
The FDA submission is based on the positive results of the pivotal Phase 3 REFLECT trial. "Based on the activity observed in the REFLECT trial, Eisai is eager to work with the U.S. FDA and regulatory agencies worldwide with the hope of quickly bringing lenvatinib to patients with liver cancer." There is no guarantee that any investigational uses o
8/11/17 - Far Afield
I don't know if you've heard about last month's big healthcare controversy in England. An infant, less than a year old, with a rare fatal genetic disease was refused permission to come to the United States for an experimental treatment that would, at best, have added a few weeks to his tragically short life. It turned out that the American doctor h
8/11/17 - Glad to survive poisoned banana, thanks to Diatom
ALMOST excluded sublingual Vitamin B2 from my diet last month after the second close encounter with fainting in about two weeks. The first spell occurred just after lunch in the office. Suddenly, I remembered that I had not taken sublingual Vitamin B2 which is a part of my dietary food supplement whenever my ophthalmologist spots cataract developin
8/11/17 - IACTA Pharmaceuticals' Licensed Technology Receives Royal Society of Chemistry Award
By a News Reporter-Staff News Editor at Drug Week IACTA Pharmaceuticals, Inc. announced that the technology used in its dry eye candidate product NM133, Molecular Envelope Technology, was recently awarded first prize in the Royal Society of Chemistry's Emerging Technologies Competition. IACTA Pharmaceuticals partnered with UK- based Nanomerics, L
8/11/17 - Immunicum AB (publ) Announces Enrollment of First United States Patient in the Ongoing Phase 2 MERECA Trial for Ilixadencel [T-break Tech (Middle East)]
Immunicum AB Announces Enrollment of First United States Patient in the Ongoing Phase 2 MERECA Trial for Ilixadencel. Immunicum AB, a biopharmaceutical company advancing a novel immuno-oncology treatment against a range of solid tumors, today announced the enrollment of the first patient in the United States as part of the Company`s ongoing global
8/11/17 - John Snow Focuses Practice on Hatch-Waxman Work
Polsinelli, an Am Law 100 firm, announced today that intellectual property litigator John Snow joined its Chicago office as a shareholder. He has served as trial counsel for various patent litigations in U.S. federal courts and has experience counseling biosimilar manufacturers and formulating strategies regarding the BPCIA. Snow prepares and prose
8/11/17 - Kura Oncology Announces Pricing of Public Offering of Common Stock
Kura Oncology, Inc., a clinical-stage biopharmaceutical company focused on the development of precision medicines for oncology, today announced the pricing of an underwritten public offering of 7,700,000 shares of its common stock at a price to the public of $6.50 per share. The gross proceeds to Kura Oncology from the offering, excluding any exe
Articles(s): 1 - 25 of 250     Next >>     Go To Page:


© 2017 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool
Drug Therapy Management Series Part III: Geriatric Disorders
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415